Endophthalmitis Then and Now

More than a century of innovation has transformed how endophthalmitis is prevented, diagnosed, and treated.

By Landon J. Rohowetz, MD, Patrick C. Staropoli, MD, Stephen G. Schwartz, MD, MBA, et al.

The Clinical Trial Team Gets an AI Teammate

Artificial intelligence may bring a paradigm shift by dramatically improving the efficiency of clinical trial sites.

By Mark R. Barakat, MD, Ram Yalamanchili

Stem Cell Therapies for Retinal Degenerations

This approach holds promise for preserving and restoring vision in AMD, RP, and beyond.

By Noah M. Heaps, BS, Maximilian D. Kong, BS, Aykut Demirkol, MD, et al.

Heads-Up Surgical Display Systems Come Into Focus

Digital platforms are transforming ergonomics, visualization, and education in retina.

By Shivesh H. Shah, BA, John B. Miller, MD

Microbots as a Potential Treatment for Vitreous Hemorrhage

A Conversation with Louis William Rogowski, PhD, and Min Jun Kim, PhD.

By Jim Gallagher, senior managing editor

Upfront: Technology and the Retina

By Diana V. Do, MD

Coding Q&A: Proper Documentation for Diagnostic Tests

Follow CMS guidelines to ensure compliance and minimize claim denials when ordering diagnostic tests.

By Elizabeth Cifers, MBA, MSW, CHC, CPC

Clinical Trial Update May 2025

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.